A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Conditions
Alzheimer Disease · Healthy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Collaborative Neuroscience Network - CNS, Los Alamitos, California, United States
Contact: Principal Investigator (Steven Reynolds)K2 Medical Research - The Villages, Lady Lake, Florida, United States
Contact: Principal Investigator (Craig Curtis)K2 Medical Research, Maitland, Florida, United States
Contact: Principal Investigator (Brandon Lenox)Aqualane Clinical Research, Naples, Florida, United States
Contact: Principal Investigator (William Justiz)Progressive Medical Research, Port Orange, Florida, United States
Contact: Principal Investigator (Alexander White)K2 Medical Research - Tampa, Tampa, Florida, United States
Contact: Principal Investigator (Kelley Wilson)Atlanta Center of Medical Research, Atlanta, Georgia, United States
Contact: Principal Investigator (Elyssa Barron)CenExel iResearch, LLC (CenExel iRA), Decatur, Georgia, United States
Contact: Principal Investigator (Kimball Johnson)QUEST Research Institute, Farmington Hills, Michigan, United States
Contact: Principal Investigator (Aaron Ellenbogen)CenExel-HRI, Marlton, New Jersey, United States
Contact: Principal Investigator (Elan Cohen)Duke Early Phase Research Unit, Durham, North Carolina, United States
Contact: Principal Investigator (Shruti Raja)The University of Tokyo Hospital, Bunkyō City, Japan
Contact: Principal Investigator (Yoshiki Niimi)National Center for Geriatrics and Gerontology, Ōbu, Japan
Contact: Principal Investigator (Keisuke Suzuki)
Study leads
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company